Answers are grounded in this paper and cite their sources.
A few years ago I published a small monograph entitled Ligand-Receptor Energetics (1.Klotz I.M. Ligand-Receptor Energetics. John Wiley and Sons, Inc., New York1997Google Scholar) and dedicated it to a number of individuals “whose contributions are no longer remembered.” This volume assembles in a logical array the major features of the concepts and procedures developed in the core area of my research interests. Unlike most of my contemporaries, I did not spend a postdoctoral period or a sabbatical leave in the laboratory of a distinguished scientist. Nevertheless, I have profited enormously from shorter periods of contact with some of the extraordinary individuals of the 20th century, including in my younger days, J. Franck, P. Debye, J. D. Bernal, S. Goudsmit, O. Loewy, E. Chargaff, A. Szent-Gorgyi, and M. Kac. From them and others I obtained numerous valuable insights and wise maxims, of which the following are a sampling. J. Franck: “always multiply by a factor of 3 an experimenter's claim of the uncertainty of his results.” P. Debye: “even when a very prestigious scientist states a “fact,” be cautious.” In an early decade of the 20th century, Debye calculated theoretically what the dipole moment of HCl (I think) is and obtained a value of (let us say) 1.85 (Debye units). The then available experimental value was markedly lower (let us say 1.40). New experimental studies were undertaken, therefore, by a succession of physicists, and these yielded dipole moments progressively closer to 1.85. At this point, for reasons that I have forgotten, Debye was prompted to reexamine his theoretical calculation. Lo and behold he discovered he had made an error in his earlier theoretical computation. When corrected, the theory now led to a dipole moment of 1.40, in agreement with the first experiments, which thereafter were widely confirmed. O. Loewy: “before giving a seminar, it is more important to have an empty bladder than a full mind.” E. Chargaff: “so-called model experiments are carried to incredible lengths prompting one to say that confusion superimposed on complexity may produce papers but not results. [After all] a skunk dipped in chlorophyll is not yet a rose bush.” A. Szent-Gorgyi: “when I first took up fishing, I always used an enormous hook... [it is] more exciting not to catch a big fish than not to catch a small one... Now I have reduced the size of my hook.” However, these individuals were not the only ones “on whose shoulders I have stood” to attain the understandings I have reached of ligand-receptor interactions. The achievements of the less known men provided the foundations for the creations of their successors, yet their names have largely been lost to succeeding generations. My interest in ligand-receptor interactions was first aroused in 1942 when I read an article by P. H. Bell and R. A. Roblin (2.Bell P.H. Roblin R.A. J. Am. Chem. Soc. 1942; 64: 2905-2917Crossref Scopus (172) Google Scholar) on the relative effectiveness of a series of sulfa drugs of different structures. From the late fall of 1940 until the spring of 1945, I was fully engaged in a number of wartime research projects established by the National Defense Research Committee (NDRC) at Northwestern University and was also teaching two courses every term. Nevertheless, I found occasional opportunities to read a few journals, which at that time appeared monthly and were at most a centimeter thick. In the early 1940s penicillin was unknown to the public, but the sulfa drugs, discovered around 1930, were being extensively and effectively used, particularly against pneumonia. Novel structures were being synthesized by pharmaceutical houses. Bell and Roblin (2.Bell P.H. Roblin R.A. J. Am. Chem. Soc. 1942; 64: 2905-2917Crossref Scopus (172) Google Scholar) found that the bacteriostatic activity of their hundred sulfonamides at pH 7 increased as the acid of pK of the compound decreased toward 7 but that a further increase in acid strength resulted in declines in activity. Then current opinion attributed sulfonamide activity to binding of the drug by an enzyme within the bacterial cell, which blocked enzymatic activity. It occurred to me that in that case if the relative affinity of the anion of a sulfonamide for the enzyme paralleled its affinity for H+, then I could account for the bell-shaped activity-pK curve for the series of sulfonamides described by Bell and Roblin (2.Bell P.H. Roblin R.A. J. Am. Chem. Soc. 1942; 64: 2905-2917Crossref Scopus (172) Google Scholar). A full quantitative development of this concept was published in 1944 (3.Klotz I.M. J. Am. Chem. Soc. 1944; 66: 459-464Crossref Scopus (8) Google Scholar). One might raise the question at this point, why was it essentially universally accepted at that time that when a substance has a physiological effect on an organism, the effector molecule must be combining with a receptor. This was certainly not self-evident in earlier centuries and millennia. In the Western world the concepts formulated by Galen 2000 years ago (standing on the shoulders of some of his predecessors, such as Hippocrates) dominated medical practice. In essence Galen's foundational premise was that a human being was healthy so long as there was a proper balance between the four humors: phlegm, black bile, yellow bile, and blood. For example, bloodletting was a widely accepted procedure in the treatment of a disturbance in this equilibrium manifested as a disease (including George Washington's final, fatal illness). In the Far East, yin and yang constituted two complementary principles that control health and permeated all features of human life. Medicinals operated by shifting the distribution between yin and yang. Only decades after 1944 did I return to this enigma and try to find when the transition to modern views of effector-receptor combination occurred. It is often difficult to pinpoint precisely the first appearance of a new insight. As far as I can tell, it was a physicist, not a life scientist, who provided the first vision of a molecular interaction between two substances of physiological impart. G. G. Stokes, in the middle of the 19th century, was Lucasian Professor at Cambridge University, one in the long line of towering theoretical physicists (from Isaac Newton to Stephen Hawking) to hold that appointment. In addition to being a great theorist, he was also a talented experimentalist, particularly in developing spectroscopic methods for examining chemical substances and reactions and for studying blood. It was Stokes who first recognized, from changes in spectra when oxygen (O2) was removed from and subsequently added to blood, that oxygen combined with hemoglobin, i.e. that a complex was formed (4.Stokes G.G. Proc. R. Soc. Lond. B Biol. Sci. 1864; 13: 355-369Crossref Google Scholar). During the last two decades of the 19th century, J. N. Langley, a British physiologist and histologist, in studies of the effects of extracts of glandular secretions on heart action, concluded that these substances act directly on the cardiac tissue, i.e. they are bound (see Ref. 5.Gillispie C.C. Dictionary of Scientific Biography. 4. Charles Scribners, New York1976: 295-305Google Scholar). Subsequently, from experiments with curare and nicotine, he proposed that these substances competed with each other to form a “chemical compound” with some constituent of muscle tissue. After the turn into the 20th century, he expressed even more general views that “receptive substances” reacted with specific drugs (“chemical bodies”). It was Paul Ehrlich, a contemporary of Langley's, who created the widest and deepest understanding of effector-receptor interactions and used his insights for the systematic development of new drugs. In a sense he was a fortunate beneficiary of fate. Aniline dyes had been introduced into microscopy by Carl Weigert, a cousin of Ehrlich's mother. It was in Weigert's laboratory that Ehrlich initiated his studies of selective staining of dyes on blood cells and on tissues, publishing his first paper in 1877 (see Ref. 5.Gillispie C.C. Dictionary of Scientific Biography. 4. Charles Scribners, New York1976: 295-305Google Scholar). Being in a chemistry environment, Ehrlich formulated his ideas in chemical terms, speaking of “chemical affinities” in biological processes (e.g. toxin/antitoxin or antigen/antiserum complexes, “magic bullets” seeking specific targets). Some three decades of his experiences were epitomized in his P. Ehrlich an from the University of and in was the which substance is not it is by a to my 1944 I then that the used to the effects of sulfonamides on to be to other and physiological effector-receptor interactions. I was in no to experiments, I on the for such studies with a than an enzyme within a were a few that some drugs or bound to blood or The of these was one from D. J. Google Scholar) who the binding of some sulfonamides by but the were as of the drug In the of these I did find that two had been from a molecular binding and the binding of by had the earlier and longer The concept of effector-receptor complex by Ehrlich, Langley, and Stokes provided a molecular but this was only in a to or could be the of an equilibrium had to The of this appeared first in papers by M. and P. the whose studies led them to the of the of (see Ref. A of 4. and Scholar). a decade J. and H. introduced the and from that J. H. a to the concept of an equilibrium (see Ref. I.M. John Wiley and Sons, New Scholar). For hemoglobin, the such studies from G. G. Scholar). a molecular of for hemoglobin, to of its of he the equilibrium in of a as a combination of on the one the the of his contemporary formulated the of equilibrium which for is the The of bound of may be by which is also the of the in a some one can the In this to a found that his experimental a curve of the in the of the 20th century, it had that of the equilibrium in of a complex could not be and by A. Scopus Google Scholar) that the oxygen curve was in equilibrium of the form in that can produce a in the oxygen curve for is as J. Scholar). This that has a to hold of and that these of are bound not in a these as a of is by The of this is of the in From one can also the which is known as the The the be a line with a of the number of for in the general case for the on the molecule of are often published for other ligand-receptor It is not widely that the is essentially an the of with with particularly for its experimental the that a a value for of yet it is now known that has four binding for and not a are that when more than of is bound by a there are different of in of equilibrium This was first by E. J. Am. Chem. Soc. Scopus Google Scholar) who an of the a acid binding more general that is to all of ligand-receptor complexes, can by the in in which a is the and the lower on the by The are the equilibrium for the molecular The two equilibrium and are the which fully the binding of to receptor. One can also an for binding of that the four equilibrium At that I to and and found that the is described by 3 or by and the by or by D. and I published a paper I.M. J. Biol. Chem. Google Scholar) that the general case of an that is one with A of the of and equilibrium for some small of is in I (1.Klotz I.M. Ligand-Receptor Energetics. John Wiley and Sons, Inc., New York1997Google Scholar). there is no to all the one a binding so of binding for an of binding number of binding number of binding in a new During the first of the 20th century, there had also been a number of studies of the of had formulated for the when are bound R. J. Am. Chem. Soc. Scopus Google J. Am. Chem. Soc. Scopus Google Chem. 1942; Scopus Google Scholar). The treatment by J. Am. Chem. Soc. Scopus Google Scholar) was the most and It was my when years I to for ligand-receptor in the of 1945, the in was in the and in the National Defense Research Committee (NDRC) that the had three so it was that the in the also to and its by the of 1945, I had time to a research to for the binding of an molecule by a that could I a whose could be and example, by its of the the had a for and had obtained one of the first by I some whose structures were of Ehrlich's During the human had been on an on the of procedures developed by a by E. J. of the this in a procedure to for and in and it was not However, in and a major had also which I from who at but its was by Professor an A to a of the of one of the individuals at so I from a of of the me my first research for the of that I two at the then of the of that had created a of quantitative ligand-receptor binding In with the experimental I to the for the only binding and on the of J. Am. Chem. Soc. Scopus Google Scholar) and of J. Am. Chem. Soc. Scopus Google Scholar). the were to the to of the binding was a very for in the of every of was by and to During the fall of I a on the binding of by the as and it was published early in I.M. J. Am. Chem. Soc. Scopus Google Scholar). The binding a of so that the of bound of the for the and equilibrium were for a as in From these it that the of bound of is to the by A I.M. Google Scholar) that B could also be expressed in of the which is the of the is For the of the binding is the more It was used to the binding for each of the in Ref. I.M. J. Am. Chem. Soc. Scopus Google For the are in were on experimental of a and B from to This provided a for studies of ligand-receptor binding for binding of by in a new this one could the to which provided It was then that one could also the and if one the of with For the of Ref. I.M. J. Am. Chem. Soc. Scopus Google the were published in I.M. J. Am. Chem. Soc. Scopus Google Scholar). I was very to find that the of complex was small and the was In essence that that the of complex was not to a in or but to an increase in the an when two molecular into a The was therefore, that the from the of as and the could such a in these interactions was a to Subsequently, I that a decade earlier J. A. Soc. Scopus Google Scholar) had such effects in reactions of in molecular the on created a to the area of the for ligand-receptor and for a can these into three and between a and an to a combination has been a of opinion for a are that when he in the that in into two and I.M. and from the Scholar). After as each as by with a to the of the and and to the of the between this in a but in a the be the of the in the not a in the of the For is so the be but not why and as his ideas in his was in After his at the University of to a his earlier at the was a distinguished This was so to a in the that it did not to a a years after his was the in the it has been that there are in and ones then it has been that such as are at in for the of At other the of such in an has been as very I.M. Biol. 13: Google Scholar). In and I I.M. J. Chem. Scopus Google Scholar) to at a model for such an in spectra in the that the equilibrium for the of the to form the is it is not that an interaction by a to the of a The concept of the was or in by M. Scopus Google J. Chem. Scopus Google J. Am. Chem. Soc. Scopus Google Scholar) Scopus Google is on paper from he was a at the interaction and was with the of the few individuals are of As has been I.M. Chem. it is more important to a for a than to years in a paper with A. E. in Proc. Sci. S. A. Google Scholar) on the of described the that could in specific and a value of to a with the being the lower is by to the of the for the Nevertheless, it was universally accepted for in and used to and changes in if one an of of one proposed that had been in from to the in the when and his found that the of in has an of they it to the to three in to a In a and the effects of to its to in of its known This of effects widely to the more have to an in of with to the I not to that had no for his the the early of this century, molecular of such as acid had been in the and had the of was it that must be of the of the equilibrium then led to the or of the around 7 However, if are at this is not a to the in the However, that is not what one to for a that might be in a the is in in the is to with so the in can It to me at that time that a of the and directly the of the and I I.M. J. Am. Chem. Soc. Scopus Google Scholar) found that in the could be for this with as for and found the of to be and in the and This from very to to as as the in that the in an is Nevertheless, if there is a of and as in a to the of and a may be most that the concept of a was to Proc. Sci. S. A. Scopus Google Scholar) on in it had a earlier The of the or the as it was as a in also the of and the of for from to but the most early of from M. In in an article in Chem. Scopus Google Scholar) that was on a he had at an in formulated the of and as as the for Then he that with two or three turn could account for the of he that a of a the of the of In a he Chem. Scopus Google Scholar) also there is this which three a of the but and Proc. Sci. S. A. Scopus Google Scholar) from and by model that the turn and was the In to and which can be in the a of and molecular interactions. The into interactions from J. D. the of the and the of the and is an of his was the in who them as including all and molecular other than between and a number of new interactions have been recognized, and their have been in the 20th century, largely of P. Debye, dipole moments of to of were and they were it that and even between must After was discovered a of the of with time within a molecule that an even in it was also that structures have their This interactions between different In it has also been found that the moments with the are a for of with such as or or even with such as (see Ref. I.M. Ligand-Receptor Energetics. John Wiley and Sons, Inc., New York1997Google For most life all of these interactions are within the The of an molecule is one of the are in so they have also been For decades the has been used as with and this most of the the theoretical H. in used the to of in H. The of University Scholar). In the of of of has led to the as a model of a In this the of the is as a very environment, even a of a is I.M. Biol. 13: Google A. Proc. Sci. S. A. Scopus Google Scholar). The in or a every few and each of these a dipole the dipole moment is and for and New The of within the volume of a is I.M. Biol. 13: Google Scholar). In there are from and The is in the new insights to on the of and of of A paper was that of J. D. and R. H. in J. Chem. Scopus Google Scholar). In that they a of the of and the effects of different in of and Subsequently, J. A. Soc. Scopus Google Scholar) and H. S. and M. J. Chem. 13: Scopus Google Scholar) that are in the is or This they as to the of around It has also been known for a that can form or with have been obtained with of including (1.Klotz I.M. Ligand-Receptor Energetics. John Wiley and Sons, Inc., New York1997Google I.M. M. on the J. and A. Scholar). Some of these are to and even it is that is a substance in to being of a of structures to a of structures. could to the of a molecule and of its with In has of within and on the of Proc. Sci. S. A. Google Scopus Google J. Sci. Scopus Google Scholar). In proposed Chem. Scopus Google Scholar) that the be for interactions between that are by a In ligand-receptor there are of that are of a and others with a (1.Klotz I.M. Ligand-Receptor Energetics. John Wiley and Sons, Inc., New York1997Google Scholar). For example, in the series and binding by is with the following In this the to a as the of the In interactions is the major to the (1.Klotz I.M. Ligand-Receptor Energetics. John Wiley and Sons, Inc., New York1997Google Scholar). In it is to that in interactions with small or there are different of that are and with each This enormous complexity in interactions has been only (1.Klotz I.M. Ligand-Receptor Energetics. John Wiley and Sons, Inc., New York1997Google J. J. Scopus Google Scholar). One must also be that the are in an that also of of interaction to specific of binding are In such it is not to the of specific of or This has been for a in of of It can be in form by what is the of a in the volume of a is not a of the molecular of a of in it changes in the the and are in their interactions. one can is the the of the when a of is For example, a of in in and in in to in the and more are for some in For is with for the is the of in is with for the the volume by the of in is not the value of is that if is added to the volume of the there must be a interaction of the with the From a molecular one that this a in the volume of the In with the interactions are even more one not of the for example, a within a of the of all of interactions within the one and a form of One might of the chemical or as one can for a in However, it is not one could for a of interaction within a When it has to a with a theory on have developed have been used for of years in and for a in In with the development of very interactions are to are now also widely used to molecular in interactions. As these procedures to be it us to be of the of theoretical P. is to have the theory which the than to have an which of time an In I also that I have profited from of of individuals with or no with me to The only he as a at University, was the one in Nevertheless, this wise and made one of the most to all for and New it or leave it the to may be only
No takes yet. Share an insight, caveat, or question.
Irving M. Klotz (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: